Corticosteroids + Cyclosporine + mycophenolate mofetil
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pediatric Liver Transplantation
Conditions
Pediatric Liver Transplantation
Trial Timeline
May 1, 2003 → Jan 1, 2005
NCT ID
NCT02630563About Corticosteroids + Cyclosporine + mycophenolate mofetil
Corticosteroids + Cyclosporine + mycophenolate mofetil is a phase 2 stage product being developed by Roche for Pediatric Liver Transplantation. The current trial status is terminated. This product is registered under clinical trial identifier NCT02630563. Target conditions include Pediatric Liver Transplantation.
What happened to similar drugs?
3 of 19 similar drugs in Pediatric Liver Transplantation were approved
Approved (3) Terminated (0) Active (16)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02630563 | Phase 2 | Terminated |
Competing Products
20 competing products in Pediatric Liver Transplantation